# Preeclampsia Postpartum Antihypertensive Treatment

> **NCT04298034** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Medical College of Wisconsin** · enrollment: 300 (estimated)

## Conditions studied

- Preeclampsia
- Hypertension in Pregnancy

## Interventions

- **DRUG:** Labetalol, Nifedipine

## Key facts

- **NCT ID:** NCT04298034
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-07-17
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04298034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04298034, "Preeclampsia Postpartum Antihypertensive Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04298034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*